News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,685 Results
Type
Article (39054)
Company Profile (279)
Press Release (646352)
Section
Business (203873)
Career Advice (1991)
Deals (35364)
Drug Delivery (85)
Drug Development (80800)
Employer Resources (168)
FDA (16088)
Job Trends (14805)
News (344555)
Policy (32437)
Tag
Academia (2530)
Alliances (49090)
Alzheimer's disease (1229)
Approvals (16020)
Artificial intelligence (130)
Bankruptcy (352)
Best Places to Work (11538)
Biotechnology (200)
Breast cancer (120)
Cancer (1087)
Cardiovascular disease (97)
Career advice (1660)
Cell therapy (234)
Clinical research (64252)
Collaboration (388)
Compensation (200)
COVID-19 (2530)
C-suite (94)
Data (1126)
Diabetes (152)
Diagnostics (6139)
Earnings (84821)
Employer resources (146)
Events (109502)
Executive appointments (310)
FDA (16627)
Funding (353)
Gene therapy (178)
GLP-1 (577)
Government (4325)
Healthcare (18670)
Infectious disease (2615)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16303)
Job creations (3624)
Job search strategy (1417)
Layoffs (412)
Legal (7853)
Lung cancer (170)
Manufacturing (176)
Medical device (13175)
Medtech (13180)
Mergers & acquisitions (19142)
Metabolic disorders (402)
Neuroscience (1504)
NextGen Class of 2024 (6500)
Non-profit (4466)
Northern California (1481)
Obesity (232)
Opinion (179)
Patents (102)
People (56276)
Phase I (19955)
Phase II (28303)
Phase III (21099)
Pipeline (458)
Postmarket research (2554)
Preclinical (8494)
Radiopharmaceuticals (236)
Rare diseases (219)
Real estate (5890)
Regulatory (21525)
Research institute (2309)
Resumes & cover letters (349)
Southern California (1302)
Startups (3563)
United States (13499)
Vaccines (549)
Weight loss (168)
Date
Today (79)
Last 7 days (682)
Last 30 days (3727)
Last 365 days (35687)
2024 (32752)
2023 (40077)
2022 (51178)
2021 (55714)
2020 (54089)
2019 (46544)
2018 (35022)
2017 (32110)
2016 (31483)
2015 (37554)
2014 (31319)
2013 (26345)
2012 (28571)
2011 (29264)
2010 (27332)
Location
Africa (713)
Arizona (192)
Asia (37127)
Australia (6060)
California (3331)
Canada (1295)
China (252)
Colorado (147)
Connecticut (153)
Europe (79514)
Florida (461)
Georgia (116)
Illinois (341)
Indiana (196)
Kansas (96)
Maryland (575)
Massachusetts (2610)
Michigan (158)
Minnesota (273)
New Jersey (957)
New York (964)
North Carolina (702)
Northern California (1481)
Ohio (139)
Pennsylvania (847)
South America (1091)
Southern California (1302)
Texas (465)
Utah (90)
Washington State (362)
685,685 Results for "mmi inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
MMI Completes First Symani® Clinical Cases in the U.S. Following FDA Commercial Authorization
MMI (Medical Microinstruments, Inc.) today announced the completion of its first clinical cases in the United States using the Symani® Surgical System.
May 1, 2024
·
3 min read
MMI Receives FDA Authorization to Commercialize Symani® Surgical System in the U.S.
MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced that its Symani® Surgical System is now commercially available in the United States.
April 8, 2024
·
4 min read
BioMidwest
MMI Raises $110 Million in Series C Financing
MMI, a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, announced that it has raised $110 million in Series C financing.
February 21, 2024
·
3 min read
MMI to Present at the 42nd Annual J.P. Morgan Healthcare Conference
MMI (Medical Microinstruments, Inc.) today announced the company has been invited to participate in the 42nd Annual J.P. Morgan Healthcare Conference taking place in San Francisco.
January 4, 2024
·
2 min read
BioMidwest
MMI’s Symani® Robotic Surgical System Surpasses 500 Clinical Procedures
MMI, a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, announced the successful completion of over 500 in-human surgeries with the Symani® Surgical System in the European Union.
September 25, 2023
·
4 min read
MMI to Present at the 41st Annual J.P. Morgan Healthcare Conference
MMI ( Medical Microinstruments, Inc. ), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced that it will participate in the 41st Annual J.P. Morgan Healthcare Conference taking place in San Francisco, California on January 9-12, 2023.
January 4, 2023
·
1 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Boston Scientific Closes Acquisition of Axonics, Inc.
November 15, 2024
·
5 min read
Press Releases
TearSolutions, Inc. Secures $3M Series B Funding
November 22, 2024
·
1 min read
1 of 68,569
Next
